“Economic Consequences of Administering Obinutuzumab As a Short Duration Infusion in Italian Patients With Advanced Follicular Lymphoma: A Cost Analysis”. Farmeconomia. Health Economics and Therapeutic Pathways 23, no. 1 (November 7, 2022). Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1532.